Among the patients who had gBRCA1, the median age at the diagnosis of breast cancer was 39.5 years in those with concurrent mutation in TP53, compared to 45 years without TP53. The patients also had significantly more premenopausal status and higher Ki-67 values (p = 0.044, 0.006, respectively). This evidence concerns the gene MKI67 and breast cancer.